401 Epizód

  1. Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series

    Közzétéve: 2021. 08. 20.

  2. Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series

    Közzétéve: 2021. 08. 16.

  3. Episode 121: Conflicts of Interest with the podcasts

    Közzétéve: 2021. 08. 04.

  4. Episode 119: EAU - Surgery in urothelial cancer

    Közzétéve: 2021. 07. 23.

  5. Episode 118: Prostate cancer highlights at EAU

    Közzétéve: 2021. 07. 20.

  6. Episode 117: PD1/VEGF adverse event management in renal cancer

    Közzétéve: 2021. 07. 20.

  7. Episode 116: Renal cancer surgery controversies at EAU

    Közzétéve: 2021. 07. 14.

  8. Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population

    Közzétéve: 2021. 07. 05.

  9. Episode 115: Triplet therapy for 1st line metastatic prostate cancer

    Közzétéve: 2021. 07. 01.

  10. Episode 114: Radionucleotides in prostate cancer

    Közzétéve: 2021. 06. 18.

  11. Episode 113: ASCO 2021 Enazlutamide +/- Radium-223

    Közzétéve: 2021. 06. 18.

  12. Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer

    Közzétéve: 2021. 06. 08.

  13. Episode 110: PEACE1 - Triplet therapy in prostate cancer

    Közzétéve: 2021. 06. 08.

  14. Episode 109: Adjuvant pembrolizumab in renal cancer

    Közzétéve: 2021. 06. 07.

  15. Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer

    Közzétéve: 2021. 06. 07.

  16. Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing

    Közzétéve: 2021. 06. 07.

  17. Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021

    Közzétéve: 2021. 06. 07.

  18. Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer

    Közzétéve: 2021. 06. 07.

  19. Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer

    Közzétéve: 2021. 06. 06.

  20. Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer

    Közzétéve: 2021. 06. 06.

15 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site